Welcome to our dedicated page for Alphatec Hldgs news (Ticker: ATEC), a resource for investors and traders seeking the latest updates and insights on Alphatec Hldgs stock.
Alphatec Holdings, Inc. (Nasdaq: ATEC) is a spine-focused medical device company whose news flow centers on spine surgery innovation, financial performance, and strategic collaborations. Through subsidiaries such as Alphatec Spine, Inc., EOS imaging S.A.S., and SafeOp Surgical, Inc., ATEC regularly issues updates on procedural technologies, imaging platforms, and neuro-monitoring systems that support its goal of revolutionizing spine surgery.
Investors and clinicians following ATEC news can expect frequent announcements of quarterly and annual financial results, including commentary on surgical revenue, EOS revenue, adjusted EBITDA, and free cash flow. The company often pairs its earnings releases with updated full-year outlooks, highlighting trends in surgical volume growth, new surgeon adoption, and the performance of its procedural ecosystems such as PTP™ and LTP™.
ATEC’s news stream also features product and platform launches, such as the commercial introduction of the PTP™ Corpectomy system, which expands its Prone TransPsoas approach to complex thoracolumbar pathologies. These announcements provide detail on systems like the Sigma™ LIF Corpectomy Access System, Ascend™ NanoTec™ Vertebral Body Replacement System, and SafeOp™ Neural InformatiX™ System, illustrating how the company integrates access, implants, and neuro-monitoring into a unified procedural offering.
Strategic and corporate developments are another recurring theme. Recent news includes a definitive partnership with Theradaptive, Inc. granting ATEC exclusive U.S. commercial rights to OsteoAdapt®, an osteoinductive bone graft for spinal fusion built on AMP2™ protein technology. The company also issues releases about participation in major healthcare and medtech conferences, board-related updates, and inducement equity awards for new employees. This news page aggregates these items so readers can track how ATEC’s spine-only strategy, innovation pipeline, and financial trajectory evolve over time.
Alphatec Holdings, Inc. (NASDAQ: ATEC) has announced the pricing of an underwritten registered offering of 4,285,715 shares of common stock at a price of $14.00 per share. This move is expected to generate approximately $60 million in gross proceeds before underwriting discounts and commissions. The offering is scheduled to close on or about April 21, 2023, and the shares are being offered under a shelf registration statement that was declared effective on April 19, 2023. TD Cowen is the sole book-runner for this offering. ATEC is focused on innovative solutions for spine surgery, aiming to enhance surgical goals with its Organic Innovation Machine™ and AlphaInformatiX Platform.
Alphatec Holdings, a spine surgery solution provider, has acquired the REMI Robotic Navigation System from Fusion Robotics for $55 million. This acquisition aims to enhance ATEC’s procedural strategy by integrating advanced navigation and robotics into spinal workflows. The company expects total revenue to exceed $108 million in Q1 2023, reflecting over 52% year-over-year growth. Additionally, ATEC has raised its full-year revenue guidance to $450 million, a 28% increase from the previous year. The firm anticipates achieving break-even adjusted EBITDA in 2023 and free cash flow in 2025. A live webcast will discuss these developments, scheduled for today at 2:00 PM PT.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced it will release its first quarter financial results on May 4, 2023, after the market closes. A live webcast will be hosted at 1:30 p.m. PT / 4:30 p.m. ET. Investors can access the webcast by visiting ATEC's Investor Relations Section. Following the webcast, a replay will be available for twelve months on the website, with a dial-in replay option starting two hours after the event. ATEC focuses on revolutionizing spine surgery with innovative solutions, emphasizing their Organic Innovation Machine™ and expanding AlphaInformatiX Platform.
Alphatec Holdings, Inc. (Nasdaq: ATEC) has announced participation in key investor events. The company will present at The Needham Virtual Healthcare Conference on April 17, 2023, at 12:45pm ET, and at The Bank of America Healthcare Conference in Las Vegas, NV, on May 9, 2023, at 9:20am PT. Webcasts of these presentations will be available in the Investor Relations Section of the company’s website. Additionally, ATEC has granted 33,520 restricted stock units (RSUs) to sixteen new employees as part of its employment inducement program, which will vest over four years or upon a change of control.
Alphatec Holdings, Inc. (ATEC) reported a full-year revenue increase of 44%, reaching $351 million, and $106 million for Q4 2022, a 43% year-over-year growth. The company's adjusted EBITDA margin for Q4 improved by 750 basis points. Full-year 2022 operating expenses stood at $380 million, resulting in a GAAP operating loss of $147 million. Looking ahead, ATEC projects a revenue of approximately $438 million for 2023, indicating a 25% growth, with expectations to achieve non-GAAP adjusted EBITDA break-even.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced management participation in several upcoming investor events. These include the Cowen Healthcare Conference on March 6, 2023, in Boston at 2:10 pm ET, and the Canaccord Genuity Musculoskeletal Conference in Las Vegas on March 7, 2023, at 2:30 pm PT. Other events include a virtual presentation at the Loop Capital Markets Annual Investor Conference on March 13, 2023, and the Barclays Healthcare Conference in Miami on March 15, 2023, at 2:05 pm ET. Webcasts and archived recordings of these events will be accessible via the Company’s Investor Relations section on their website.
Alphatec Holdings, Inc. (ATEC) will release its fourth quarter and fiscal year 2022 financial results on February 28, 2023, after market close. A live webcast will follow at 1:30 p.m. PT / 4:30 p.m. ET. Additionally, ATEC has granted 12,108 restricted stock units (RSUs) to seven new employees as an inducement for their employment, vesting in annual installments over four years, with full vesting upon a change of control. ATEC aims to innovate spine surgery with its Organic Innovation Machine™ and the AlphaInformatiX Platform.
Alphatec Holdings, Inc. (ATEC) reported notable preliminary financial results for Q4 and FY 2022, with total revenue rising approximately 44% to over $350 million. The company predicts a 25% revenue growth in 2023, anticipating $438 million, alongside achieving break-even adjusted EBITDA. ATEC secured a $150 million non-dilutive term loan to bolster its balance sheet, enhancing liquidity to around $275 million. Surgical revenue increased by 48% to 50%, reflecting strong adoption of the PTP™ approach. The firm plans to continue expanding its market presence in spine surgery.
Alphatec Holdings, Inc. (NASDAQ: ATEC) announced its participation in the 25th Annual Needham Growth Conference with a fireside chat scheduled for January 12, 2023, at 3:00 PM ET. The presentation will be available via webcast in the Company’s Investor Relations Section.
Additionally, the Company granted 18,048 restricted stock units to 16 new employees as part of its employment inducement awards.
Alphatec Holdings, Inc. (ATEC) reported a strong 43% growth in total revenue, reaching $90 million for Q3 2022, driven by a 53% increase in surgical revenue. The company achieved a 66% GAAP gross margin and a 71% non-GAAP gross margin. Despite operating expenses of $94 million, adjusted EBITDA improved significantly, with a margin increase of 870 basis points year-over-year. ATEC anticipates total revenue of $340 million for the full year, in line with a 40% growth rate forecasted earlier.